Skip to content

Natrelle Inspira Cohesive Breast ImplantsRecalls & reported problems across all models

Allergan, Inc. · 192 models in the FDA device registry

Data updated Oct 18, 2026 from official FDA records · Editorial policy

1 open recall names at least one Natrelle Inspira Cohesive Breast Implants model. Check whether yours is affected in the recall details, and contact the manufacturer or your healthcare provider.

Adverse event reports
2,949
Deaths reported
0
Injuries reported
2,911
Recalls
1

We found 192 models of Natrelle Inspira Cohesive Breast Implants by Allergan, Inc. in the FDA's device registry (GUDID). Together they are named in 2,949 adverse event reports in the FDA's MAUDE database, received between Nov 2, 2017 and Sep 30, 2026 — classified as 2,911 injuries, 38 malfunctions.

The most frequently reported specific device problem is “Device Appears to Trigger Rejection” (1,603 reports).

1 FDA recall record name at least one of these models by its device identifier, 1 still open.

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event. Widely used products collect more reports, so totals can't be used to compare products or estimate failure rates. Only reports that name a model's exact device identifier are counted. What reports can and can't tell you · How this data works

Reports received per month, all models

Nov 2023: 38 reportsDec 2023: 7 reportsJan 2024: 5 reportsFeb 2024: 6 reportsMar 2024: 6 reportsApr 2024: 4 reportsMay 2024: 2 reportsJun 2024: 12 reportsJul 2024: 5 reportsAug 2024: 1 reportsSep 2024: 11 reportsOct 2024: 7 reportsNov 2024: 2 reportsDec 2024: 1 reportsJan 2025: 5 reportsFeb 2025: 0 reportsMar 2025: 5 reportsApr 2025: 38 reportsMay 2025: 58 reportsJun 2025: 59 reportsJul 2025: 50 reportsAug 2025: 67 reportsSep 2025: 47 reportsOct 2025: 19 reportsNov 2025: 11 reportsDec 2025: 20 reportsJan 2026: 22 reportsFeb 2026: 15 reportsMar 2026: 27 reportsApr 2026: 43 reportsMay 2026: 23 reportsJun 2026: 20 reportsJul 2026: 41 reportsAug 2026: 28 reportsSep 2026: 48 reportsOct 2026: 0 reports20242025202667
Last 36 months. The most recent month may be incomplete.

Natrelle Inspira Cohesive Breast Implants recalls

FDA recall records that name at least one of these models by its device identifier, newest first. Each recall usually covers specific models or lots, so check the details.

  1. Jul 24, 2019Class IOpen, Classified

    The action was initiated following notification by the U.S. FDA of their recently updated, global safety information concerning the higher incidence of anaplastic large cell lymphoma (BIA-ALCL) in patients who have textured breast implants.

    Z-2453-2019 · Root cause: Unknown/Undetermined by firm · names 100 of these models · Recall details · FDA record ↗

Most reported Natrelle Inspira Cohesive Breast Implants problems

Device problems

  • Device Appears to Trigger Rejection1,603
  • Patient-Device Incompatibility538
  • Material Rupture402
  • Adverse Event Without Identified Device or Use Problem357
  • Malposition of Device57
  • Migration40
  • Device Handling Problem21
  • Difficult to Open or Remove Packaging Material21

Patient problems

  • Capsular Contracture2,078
  • Failure of Implant396
  • Unspecified Infection193
  • No Clinical Signs, Symptoms or Conditions89
  • Seroma73
  • Wound Dehiscence54
  • Foreign Body Reaction34
  • Impaired Healing32

Natrelle Inspira Cohesive Breast Implants models

192 models, 100 per page, most reported first. Each model has its own page with its reports, recalls and device details.

Recent Natrelle Inspira Cohesive Breast Implants adverse event reports

The 15 most recent reports across all models, in the reporter's own words as published by the FDA.

Other Allergan, Inc. products

All Allergan, Inc. devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page